A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients
- Conditions
- Interventions
- First Posted Date
- 2020-07-30
- Last Posted Date
- 2023-12-28
- Lead Sponsor
- Handok Inc.
- Target Recruit Count
- 92
- Registration Number
- NCT04492033
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
🇰🇷Samsung Medical Center, Seoul, Korea, Republic of
🇰🇷Seoul National University Bundang Hospital, Seongnam-si, Korea, Republic of
Phase 2 Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypetension
- First Posted Date
- 2020-07-28
- Last Posted Date
- 2022-06-30
- Lead Sponsor
- Handok Inc.
- Target Recruit Count
- 440
- Registration Number
- NCT04488978
- Locations
- 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
Pharmacokinetic Drug Interaction Between Teneligliptin and Empagliflozin
- Conditions
- Interventions
- First Posted Date
- 2020-06-16
- Last Posted Date
- 2021-11-15
- Lead Sponsor
- Handok Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT04431141
- Locations
- 🇰🇷
Clinical Pharmacology, Asan Medical Center, Seoul, Korea, Republic of
A Study to Assess Efficacy and Safety of the Ketoprofen vs Diclofenac
- Conditions
- Interventions
- First Posted Date
- 2020-06-09
- Last Posted Date
- 2021-01-20
- Lead Sponsor
- Handok Inc.
- Target Recruit Count
- 236
- Registration Number
- NCT04421911
- Locations
- 🇷🇺
City Clinical Hospital #1 n.a. Pirogova, Moscow, Russian Federation
🇷🇺Clinical Emergency Hospital n.a. N.V.Soloviev, Yaroslavl, Russian Federation
🇷🇺Maksimum Zdorovya, Kemerovo, Russian Federation
Theracurmin vs Curcumin Bioavailability Study
- First Posted Date
- 2019-07-23
- Last Posted Date
- 2019-12-06
- Lead Sponsor
- Handok Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT04028739
- Locations
- 🇰🇷
Korea Kuro Hospital, Seoul, Korea, Republic of
A Phase 1 Study of NOV1601(CHC2014) in Adult Subjects With Solid Organ Malignancies
- First Posted Date
- 2019-07-10
- Last Posted Date
- 2021-09-16
- Lead Sponsor
- Handok Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT04014257
- Locations
- 🇰🇷
CHA Bundang Medical Center, Seongnam, Gyeonggi-do, Korea, Republic of
🇰🇷National Cancer Center, Goyang, Gyeonggi-do, Korea, Republic of
🇰🇷Seoul National University Hospital, Seoul, Korea, Republic of
Observational Study to Evaluate the Efficacy and Safety of Teneligliptin
- Conditions
- First Posted Date
- 2019-01-04
- Last Posted Date
- 2019-01-07
- Lead Sponsor
- Handok Inc.
- Target Recruit Count
- 4875
- Registration Number
- NCT03793023
- Locations
- 🇰🇷
Ajou University Hospital, Suwon, Gyeonggi, Korea, Republic of
A Study to Evaluate the Effect of Food on Fixed-Dose Combination of MP-513 10 mg and Metformin XR 750 mg
- First Posted Date
- 2018-12-26
- Last Posted Date
- 2018-12-27
- Lead Sponsor
- Handok Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT03787043
- Locations
- 🇰🇷
Clinical trials center of Chungnam National University Hospital, Daejeon, Jung-gu, Korea, Republic of
A Study to Compare MP-513 20mg & Metformin XR 1000mg FDC With Coadministration of the Two Separate Drugs
- Conditions
- Interventions
- First Posted Date
- 2018-12-26
- Last Posted Date
- 2018-12-27
- Lead Sponsor
- Handok Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT03787017
- Locations
- 🇰🇷
Clinical trials center of Chungnam National University Hospital, Daejeon, Jung-gu, Korea, Republic of
Teneligliptin and Atorvastatin DDI Study
- Conditions
- Interventions
- First Posted Date
- 2018-12-10
- Last Posted Date
- 2019-05-30
- Lead Sponsor
- Handok Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT03769870
- Locations
- 🇰🇷
Korea Universitiy Guro Hospital, Seoul, Korea, Republic of